APA

Hasan A. A., Sabry S. A., Abdallah M. H. & El-Damasy D. A. (20170313). Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate. : Pharmaceutical development and technology.

Chicago

Hasan Azza A, Sabry Shereen A, Abdallah Marwa H and El-Damasy Dalia A. 20170313. Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate. : Pharmaceutical development and technology.

Harvard

Hasan A. A., Sabry S. A., Abdallah M. H. and El-Damasy D. A. (20170313). Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate. : Pharmaceutical development and technology.

MLA

Hasan Azza A, Sabry Shereen A, Abdallah Marwa H and El-Damasy Dalia A. Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate. : Pharmaceutical development and technology. 20170313.